oral glp 1 pfizer to discontinue danuglipron, its GLP-1 pill for obesity| STAT Are Pills the Next Big
Description
Pfizer's decision to halt development of the drug came after "a review of the totality of information, including all clinical data generated to date for danuglipron and recent input from regulators," according to a release
:max_bytes(150000):strip_icc()/WouldYouBeMoreLikelytoTakeGLP-1sifTheyCameinPill-Form_final-2741a721ac7748639cf0256d61df3b7f.png)
Se espera que la inversin genere 100 nuevos empleos en el sector manufacturero y 1,000 en la construccin
Think of it like a key and lock
Studies exclusively evaluating supraphysiologic androgen dosing, anabolic steroid misuse, or performance enhancement in eugonadal athletes were excluded

Karagiannis T, Avgerinos I, Liakos A, Del Prato S, Matthews DR, Tsapas A, Bekiari E
www.micromedex.com
